全文获取类型
收费全文 | 5441篇 |
免费 | 354篇 |
国内免费 | 43篇 |
专业分类
耳鼻咽喉 | 163篇 |
儿科学 | 120篇 |
妇产科学 | 35篇 |
基础医学 | 724篇 |
口腔科学 | 81篇 |
临床医学 | 499篇 |
内科学 | 1122篇 |
皮肤病学 | 205篇 |
神经病学 | 573篇 |
特种医学 | 328篇 |
外科学 | 1056篇 |
综合类 | 24篇 |
一般理论 | 4篇 |
预防医学 | 188篇 |
眼科学 | 63篇 |
药学 | 293篇 |
中国医学 | 8篇 |
肿瘤学 | 352篇 |
出版年
2024年 | 5篇 |
2023年 | 37篇 |
2022年 | 61篇 |
2021年 | 128篇 |
2020年 | 79篇 |
2019年 | 115篇 |
2018年 | 134篇 |
2017年 | 108篇 |
2016年 | 148篇 |
2015年 | 193篇 |
2014年 | 200篇 |
2013年 | 299篇 |
2012年 | 437篇 |
2011年 | 432篇 |
2010年 | 281篇 |
2009年 | 239篇 |
2008年 | 385篇 |
2007年 | 427篇 |
2006年 | 355篇 |
2005年 | 320篇 |
2004年 | 322篇 |
2003年 | 271篇 |
2002年 | 272篇 |
2001年 | 58篇 |
2000年 | 53篇 |
1999年 | 56篇 |
1998年 | 47篇 |
1997年 | 49篇 |
1996年 | 25篇 |
1995年 | 27篇 |
1994年 | 26篇 |
1993年 | 32篇 |
1992年 | 13篇 |
1991年 | 16篇 |
1990年 | 13篇 |
1989年 | 6篇 |
1988年 | 10篇 |
1987年 | 15篇 |
1986年 | 10篇 |
1985年 | 6篇 |
1984年 | 14篇 |
1983年 | 9篇 |
1982年 | 14篇 |
1981年 | 8篇 |
1980年 | 11篇 |
1979年 | 6篇 |
1977年 | 10篇 |
1976年 | 12篇 |
1975年 | 8篇 |
1960年 | 4篇 |
排序方式: 共有5838条查询结果,搜索用时 15 毫秒
51.
Torsten Haferlach Claudia Schoch Helmut L?ffler Winfried Gassmann Wolfgang Kern Susanne Schnittger Christa Fonatsch Wolf-Dieter Ludwig Christian Wuchter Brigitte Schlegelberger Peter Staib Albrecht Reichle Uschi Kubica Hartmut Eimermacher Leopold Balleisen Andreas Grüneisen Detlef Haase Carlo Aul Jochen Karow Eva Lengfelder Bernhard W?rmann Achim Heinecke Maria Cristina Sauerland Thomas Büchner Wolfgang Hiddemann 《Journal of clinical oncology》2003,21(2):256-265
PURPOSE: On the basis of cytomorphology according to the French-American-British (FAB) classification, we evaluated the prognostic impact of dysplastic features and other parameters in de novo acute myeloid leukemia (AML). We also assessed the clinical significance of the recently introduced World Health Organization (WHO) classification for AML, which proposed dysplasia as a new parameter for classification. PATIENTS AND METHODS: We analyzed prospectively 614 patients with de novo AML, all of whom were diagnosed by central morphologic analysis and treated within the German AML Cooperative Group (AMLCG)-92 or the AMLCG-acute promyalocytic leukemia study. RESULTS: Patients with AML M3, M3v, or M4eo demonstrated a better outcome compared with all other FAB subtypes (P <.001); no prognostic difference was observed among other FAB subtypes. The presence or absence of dysplasia failed to demonstrate prognostic relevance. Other prognostic markers, such as age, cytogenetics, presence of Auer rods, and lactate dehydrogenase (LDH) level at diagnosis, all showed significant impact on overall and event-free survival in univariate analyses (P <.001 for all parameters tested). However, in a multivariate analysis, only cytogenetics (unfavorable or favorable), age, and high LDH maintained their prognostic impact. Dysplasia was not found to be an independent prognostic parameter, but the detection of trilineage dysplasia correlated with unfavorable cytogenetics. CONCLUSION: Our results indicate that cytomorphology and classification according to FAB criteria are still necessary for the diagnosis of AML but have no relevance for prognosis in addition to cytogenetics. Our results suggest that the WHO classification should be further developed by using cytogenetics as the main determinant of biology. Dysplastic features, in particular, have no additional impact on predicting prognosis when cytogenetics are taken into account. 相似文献
52.
53.
54.
Gerhard Dongowski Bertram Fritzsch Jochen Giessler Albert H?rtl Olaf Kuhlmann Reinhard H H Neubert 《European journal of pharmaceutics and biopharmaceutics》2005,60(1):147-151
The bioavailability of orally administered drugs can be influenced by interactions with food components and by physico-chemical conditions in the upper gastrointestinal tract. Normally, bile salts enhance the transport of lipophilic drugs across mucosal membranes. Bile salts are able to form stable mixed micelles consisting of fatty acids and phospholipids. Conventional micellar systems are known to solubilize lipophilic drugs having a low bioavailability. The influence of bile salts and mixed micelles on the pharmacokinetics of the lipophilic drug quinine was investigated in rabbits. Female rabbits were given intraduadenally quinine (5 mg/kg body weight) without and with incorporation into the micellar or mixed micellar systems. Blood was collected every 30 min for 6 h. In plasma, concentration of quinine was measured using HPLC. The plasma concentration-time profiles of quinine were significantly lower within the first 2 h after administration in presence of both the sodium salt of glycodeoxycholic acid (above the critical micellar concentration) as well as of mixed micellar systems consisting of glycodeoxycholic acid and palmitic acid and/or lecithin. The pharmacokinetic parameters AUC (relative bioavailability) and c(max) of quinine were significantly decreased by micellar systems in rabbits. These mixed micellar systems lower and not as expected, increase the absorption of quinine in vivo. Therefore, quinine should be orally administered at least 1h before food intake, particularly before fat intake. 相似文献
55.
Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. 总被引:8,自引:0,他引:8
Alexander Hermani Jochen Hess Barbara De Servi Senad Medunjanin Rainer Grobholz Lutz Trojan Peter Angel Doris Mayer 《Clinical cancer research》2005,11(14):5146-5152
PURPOSE: S100 proteins comprise a family of calcium-modulated proteins that have recently been associated with epithelial tumors. We examined the expression of two members of this family, S100A8 and S100A9, together with the S100 receptor RAGE (receptor for advanced glycation end products) in human prostate adenocarcinomas and in prostatic intraepithelial neoplasia. EXPERIMENTAL DESIGN: Tissue specimens of 75 patients with organ-confined prostate cancer of different grades were analyzed by immunohistochemistry for expression of S100A8, S100A9, and RAGE. In addition, in situ hybridization of S100A8 and S100A9 was done for 20 cases. An ELISA was applied to determine serum concentrations of S100A9 in cancer patients compared with healthy controls or to patients with benign prostatic hyperplasia (BPH). RESULTS: S100A8, S100A9, and RAGE were up-regulated in prostatic intraepithelial neoplasia and preferentially in high-grade adenocarcinomas, whereas benign tissue was negative or showed weak expression of the proteins. There was a high degree of overlap of S100A8 and S100A9 expression patterns and of S100A8 or S100A9 and RAGE, respectively. Frequently, a gradient within the tumor tissue with an increased expression toward the invaded stroma of the prostate was observed. S100A9 serum levels were significantly elevated in cancer patients compared with BPH patients or healthy individuals. CONCLUSION: Our data suggest that enhanced expression of S100A8, S100A9, and RAGE is an early event in prostate tumorigenesis and may contribute to development and progression or extension of prostate carcinomas. Furthermore, S100A9 in serum may serve as useful marker to discriminate between prostate cancer and BPH. 相似文献
56.
Sebastian Bauer Hauke Lang Jochen Schütte J?rg Thomas Hartmann 《Journal of clinical oncology》2005,23(27):6800-1; author reply 6801-2
57.
Jochen Gaedcke Klaus Jung Peter Jo Hendrik A. Wolff Tim Beissbarth Thomas Ried 《Radiotherapy and oncology》2010,94(1):76-1038
Background and purpose
KRAS and BRAF are mutated in 35% and 10% of colorectal cancers, respectively. However, data specifically for locally advanced rectal cancers are scarce, and the frequency of KRAS mutations in codons 61 and 146 remains to be established.Materials and methods
DNA was isolated from pre-therapeutic biopsies of 94 patients who were treated within two phase-III clinical trials receiving preoperative chemoradiotherapy. Mutation status of KRAS exons 1-3 and BRAF exon 15 was established using the ABI PRISM Big Dye Sequencing Kit and subsequently correlated with clinical parameters.Results
Overall, KRAS was mutated in 45 patients (48%). Twenty-nine mutations (64%) were located in codon 12, 10 mutations (22%) in codon 13, and 3 mutations (7%) in codons 61 and 146. No V600E BRAF mutation was detected. The presence of KRAS mutations was correlated neither with tumor response or lymph node status after preoperative chemoradiotherapy nor with overall survival or disease-free survival. When KRAS exon 1 mutations were separated based on the amino-acid exchange, we again failed to detect significant correlations (p = 0.052). However, G12V mutations appeared to be associated with higher rates of tumor regression than G13D mutations (p = 0.012).Conclusion
We are the first to report the mutation status of KRAS and BRAF in pre-therapeutic biopsies from locally advanced rectal cancers. The high number of KRAS mutations in codons 61 and 146 emphasizes the importance to expand current mutation analyses, whereas BRAF mutations are not relevant for rectal carcinogenesis. Although the KRAS mutation status was not correlated with response, the subtle difference between G12V and G13D mutations warrants analysis of a larger patient population. 相似文献58.
Analysis of volatile organic compounds (VOCs) in the headspace of NCI-H1666 lung cancer cells 总被引:1,自引:0,他引:1
Sponring A Filipiak W Ager C Schubert J Miekisch W Amann A Troppmair J 《Cancer biomarkers : section A of Disease markers》2010,7(3):153-161
Analysis of volatile organic compounds (VOCs) provides an elegant approach for cancer screening and disease monitoring, whose use is currently limited by a lack of validated cancer-derived metabolites, which may serve as biomarkers. The aim of the experiments presented here was to investigate the release and consumption of VOCs from the non small cell lung cancer cell line NCI-H1666, which was originally derived from a bronchoalveolar carcinoma.Following detachment by trypsinization suspended cells were incubated in a sealed fermenter for 21 hours. 200 ml of headspace from the cell culture were sampled, diluted with dry, highly purified air and preconcentrated by adsorption on three different solid sorbents with increasing adsorption strength. VOC-analysis was performed by thermodesorption-gas chromatography mass spectrometry (TD-GC-MS). In contrast to our previous studies experiments with NCI-H1666 cells only confirmed the consumption of several aldehydes, n-butyl acetate and the ethers methyl tert-butyl ether and ethyl tert-butyl ether, but no unequivocal release of VOCs was observed. Together with our previously published work these data indicate that the consumption of certain VOCs is commonly observed while their release shows cell line-restricted patterns, whose underlying causes are unknown. 相似文献
59.
The role of HPV RNA transcription,immune response‐related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer 下载免费PDF全文
Knut Krohn Markus Kreuz Andreas Boehm Anett Reiche Ulrike Scharrer Dirk Halama Julia Bertolini Ulrike Bauer Dana Holzinger Michael Pawlita Jochen Hess Christoph Engel Dirk Hasenclever Markus Scholz Peter Ahnert Holger Kirsten Alexander Hemprich Christian Wittekind Olf Herbarth Friedemann Horn for the Leipzig Head Neck Group 《International journal of cancer. Journal international du cancer》2015,137(12):2846-2857
60.
Eric Wang Sydney X. Lu Alessandro Pastore Xufeng Chen Jochen Imig Stanley Chun-Wei Lee Kathryn Hockemeyer Yohana E. Ghebrechristos Akihide Yoshimi Daichi Inoue Michelle Ki Hana Cho Lillian Bitner Andreas Kloetgen Kuan-Ting Lin Taisuke Uehara Takashi Owa Raoul Tibes Iannis Aifantis 《Cancer cell》2019,35(3):369-384.e7